Encoded Therapeutics

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovascular disease, enabling medical practitioners to treat patients and improve their lives.

Encoded Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics, Genetics sector. The company focuses on Biotechnology and has secured $11.5B in funding across 48 round(s). With a team of 101-250 employees, Encoded Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - Encoded Therapeutics, raised $100.0K. Discover more about their projects, partnerships, and impact on our platform.